Further research found that in GSDME deletion cancer cells (e.g., Jurkat), chemotherapy drugs activate caspase-3, which cleaves the apoptotic substrate protein poly ADP-ribose polymerase (PARP) and leads to apoptosis [83]. The gene discussed is CASP3; the disease is cancer.